Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the beginning of 2018. Several of the CTS client forms specify list the Medical Director in the header and these forms will be updated on March 5, 2018. Check out the Communication page for a complete list of forms or by clicking the link below: Communications
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...